These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20594429)

  • 21. All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD).
    Raslan AS; Quint JK; Cook S
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1207-1218. PubMed ID: 37332839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China.
    Koch M; Butt T; Guo W; Li X; Chen Y; Tan D; Liu GG
    BMC Public Health; 2019 Dec; 19(1):1727. PubMed ID: 31870442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in the epidemiology of asthma in England: a national study of 333,294 patients.
    Simpson CR; Sheikh A
    J R Soc Med; 2010 Mar; 103(3):98-106. PubMed ID: 20200181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study.
    Terzikhan N; Verhamme KM; Hofman A; Stricker BH; Brusselle GG; Lahousse L
    Eur J Epidemiol; 2016 Aug; 31(8):785-92. PubMed ID: 26946425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.
    Adeloye D; Song P; Zhu Y; Campbell H; Sheikh A; Rudan I;
    Lancet Respir Med; 2022 May; 10(5):447-458. PubMed ID: 35279265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COPD prevalence and its association with occupational exposures in a general population.
    Melville AM; Pless-Mulloli T; Afolabi OA; Stenton SC
    Eur Respir J; 2010 Sep; 36(3):488-93. PubMed ID: 20110401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: A cross-sectional study.
    Jung JH; Lim JH; Bang CH; Seok H; Song GG; Choi SJ
    Int J Rheum Dis; 2021 Jun; 24(6):774-780. PubMed ID: 34036753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the epidemiology and prescribing of medication for allergic rhinitis in England.
    Ghouri N; Hippisley-Cox J; Newton J; Sheikh A
    J R Soc Med; 2008 Sep; 101(9):466-72. PubMed ID: 18779249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes: A protective factor for COPD?
    Rayner LH; McGovern AP; Sherlock J; Gatenby P; Correa A; Creagh-Brown B; de Lusignan S
    Prim Care Diabetes; 2018 Oct; 12(5):438-444. PubMed ID: 29843977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.
    Mytton OT; Jackson C; Steinacher A; Goodman A; Langenberg C; Griffin S; Wareham N; Woodcock J
    PLoS Med; 2018 Mar; 15(3):e1002517. PubMed ID: 29509767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in COPD prevalence and exacerbation rates in Dutch primary care.
    Bischoff EW; Schermer TR; Bor H; Brown P; van Weel C; van den Bosch WJ
    Br J Gen Pract; 2009 Dec; 59(569):927-33. PubMed ID: 19891824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care.
    Chetty U; McLean G; Morrison D; Agur K; Guthrie B; Mercer SW
    Br J Gen Pract; 2017 May; 67(658):e321-e328. PubMed ID: 28450344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active asthma and the prevalence of physician-diagnosed COPD.
    Mirabelli MC; Beavers SF; Chatterjee AB
    Lung; 2014 Oct; 192(5):693-700. PubMed ID: 24952247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England.
    Sansbury LB; Rothnie KJ; Bains C; Compton C; Anley G; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2591-2604. PubMed ID: 34552325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.
    Alqahtani JS
    PLoS One; 2022; 17(5):e0268772. PubMed ID: 35588429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of chronic obstructive pulmonary disease: a literature review.
    Rycroft CE; Heyes A; Lanza L; Becker K
    Int J Chron Obstruct Pulmon Dis; 2012; 7():457-94. PubMed ID: 22927753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic differentials of trends in the prevalence and economic burden of chronic obstructive pulmonary disease in rural southwest China.
    Cai L; Wang XM; Liu L; Zhao Y; Golden AR
    BMC Public Health; 2023 Jan; 23(1):141. PubMed ID: 36670366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales.
    Steiner MC; Lowe D; Beckford K; Blakey J; Bolton CE; Elkin S; Man WD; Roberts CM; Sewell L; Walker P; Singh SJ
    Thorax; 2017 Jun; 72(6):530-537. PubMed ID: 28077613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence, characteristics, and impact of chronic obstructive pulmonary disease in North Carolina.
    Pleasants RA; Herrick H; Liao W
    N C Med J; 2013; 74(5):376-83. PubMed ID: 24165761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epilepsy and chronic obstructive pulmonary disease among U.S. adults: National Health Interview Survey 2013, 2015, and 2017.
    Tian N; Zack M; Wheaton AG; Greenlund KJ; Croft JB
    Epilepsy Behav; 2020 Sep; 110():107175. PubMed ID: 32532551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.